Article Details

Pfizer, Merck KGaA join Immutep in Phase 1 trial for kidney cancer therapy - Seeking Alpha

Retrieved on: 2022-11-29 13:39:14

Tags for this article:

Click the tags to see associated articles and topics

Pfizer, Merck KGaA join Immutep in Phase 1 trial for kidney cancer therapy - Seeking Alpha. View article details on hiswai:

Excerpt

Australia-based biotech Immutep Limited (IMMP) announced on Tuesday a clinical trial and supply agreement with Pfizer (PFE) and Merck KGaA (MKGAF) ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up